Your browser doesn't support javascript.
loading
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer.
Meattini, Icro; Becherini, Carlotta; Boersma, Liesbeth; Kaidar-Person, Orit; Marta, Gustavo Nader; Montero, Angel; Offersen, Birgitte Vrou; Aznar, Marianne C; Belka, Claus; Brunt, Adrian Murray; Dicuonzo, Samantha; Franco, Pierfrancesco; Krause, Mechthild; MacKenzie, Mairead; Marinko, Tanja; Marrazzo, Livia; Ratosa, Ivica; Scholten, Astrid; Senkus, Elzbieta; Stobart, Hilary; Poortmans, Philip; Coles, Charlotte E.
Afiliação
  • Meattini I; Department of Experimental and Clinical Biomedical Sciences M Serio, University of Florence, Florence, Italy; Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy. Electronic address: icro.meattini@unifi.it.
  • Becherini C; Department of Experimental and Clinical Biomedical Sciences M Serio, University of Florence, Florence, Italy; Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
  • Boersma L; Department of Radiation Oncology (Maastro), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, Netherlands.
  • Kaidar-Person O; Department of Radiation Oncology (Maastro), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, Netherlands; Sheba Medical Center, Ramat Gan and Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Marta GN; Department of Radiation Oncology-Hospital Sírio-Libanês, São Paulo, Brazil; Latin American Cooperative Oncology Group, Porto Alegre, Brazil.
  • Montero A; Department of Radiation Oncology, HM Hospitales, Madrid, Spain.
  • Offersen BV; Department of Experimental Clinical Oncology, Department of Oncology, Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
  • Aznar MC; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK.
  • Belka C; Department of Radiation Oncology, LMU Klinikum, Ludwig-Maximilians University Munich, Munich, Germany.
  • Brunt AM; School of Medicine, University of Keele, Keele, UK; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
  • Dicuonzo S; Division of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
  • Franco P; Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy; Department of Radiation Oncology, Maggiore della Carità University Hospital, Novara, Italy.
  • Krause M; Department of Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden
  • MacKenzie M; Independent Cancer Patients' Voice, London, UK.
  • Marinko T; Division of Radiation Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Marrazzo L; Medical Physics Unit, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
  • Ratosa I; Division of Radiation Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Scholten A; Department of Radiotherapy, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Senkus E; Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
  • Stobart H; Independent Cancer Patients' Voice, London, UK.
  • Poortmans P; Department of Radiation Oncology, Iridium Netwerk, Antwerp, Belgium; University of Antwerp, Faculty of Medicine and Health Sciences, Antwerp, Belgium.
  • Coles CE; Department of Oncology, University of Cambridge, Cambridge, UK.
Lancet Oncol ; 23(1): e21-e31, 2022 01.
Article em En | MEDLINE | ID: mdl-34973228
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Radioterapia (Especialidade) / Seleção de Pacientes / Fracionamento da Dose de Radiação / Comitês Consultivos Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: Lancet Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Radioterapia (Especialidade) / Seleção de Pacientes / Fracionamento da Dose de Radiação / Comitês Consultivos Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: Lancet Oncol Ano de publicação: 2022 Tipo de documento: Article